Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine

Adverse birth outcomes associated with Zika virus exposure during pregnancy in São José do Rio Preto, Brazil

(2018) M.L. Nogueira et al.   CLINICAL MICROBIOLOGY AND INFECTION

Zika virus vaccines

(2018) Peter Abbink et al.   NATURE REVIEWS MICROBIOLOGY

Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice

(2018) Ran Wang et al.   VACCINE

Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus Infection

(2018) William G Valiant et al.   Open Forum Infectious Diseases

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans

(2018) Félix Delgado et al.   Viruses-Basel

Zika Virus Vaccine Development: Progress in the Face of New Challenges

(2018) Michael S. Diamond et al.   Annual Review of Medicine

Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages

(2018) Matthew G. Zimmerman et al.   Cell Host & Microbe

Zika Virus Structure, Maturation, and Receptors

(2017) Devika Sirohi et al.   JOURNAL OF INFECTIOUS DISEASES

CD8 + T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection

(2017) Huarong Huang et al.   JOURNAL OF VIROLOGY

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

(2017) Susana V. Bardina et al.   SCIENCE

Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge

(2017) Jinsheng Wen et al.   Nature Communications

Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus

(2017) Petraleigh Pantoja et al.   Nature Communications

DNA vaccination protects mice against Zika virus-induced damage to the testes

(2017) Bryan D. Griffin et al.   Nature Communications

DNA Vaccine Protects Monkeys Against Zika Virus Infection

(2016) Tracy Hampton   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals

(2016) Sandra Henein et al.   JOURNAL OF INFECTIOUS DISEASES

Structural basis of potent Zika–dengue virus antibody cross-neutralization

(2016) Giovanna Barba-Spaeth et al.   NATURE

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

(2016) Lalita Priyamvada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rapid development of a DNA vaccine for Zika virus

(2016) K. A. Dowd et al.   SCIENCE

Development and Evaluation of a SYBR Green–Based Real-Time Multiplex RT-PCR Assay for Simultaneous Detection and Serotyping of Dengue and Chikungunya Viruses

(2015) Huixin Chen et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

(2015) Luis Villar et al.   NEW ENGLAND JOURNAL OF MEDICINE

CD8+T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice

(2014) Raphaël M. Zellweger et al.   JOURNAL OF IMMUNOLOGY

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

A Protective Role for Dengue Virus-Specific CD8+ T Cells

(2009) L. E. Yauch et al.   JOURNAL OF IMMUNOLOGY